Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Sungreen Biotech is a leading Chinese biotechnology company specializing in the research, development, and industrial-scale production of natural plant extracts. Established in 1998 and headquartered in Huzhou, the company is a global pioneer in the extraction of high-purity tea polyphenols, particularly Epigallocatechin gallate (EGCG), and natural sweeteners like stevia. Sungreen's products serve as essential active pharmaceutical ingredients (APIs) and functional components for the global pharmaceutical, nutraceutical, and food industries. The company operates advanced manufacturing facilities that comply with international quality standards, including GMP, ISO, and Kosher certifications. Their expertise in separation and purification technologies supports the development of health solutions for metabolic disorders, oxidative stress, and chronic inflammation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sungreen.